FDA NDC Directory · JSON-LD · Markdown

TREANDA

NDC 63459-390 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameBendamustine Hydrochloride
Labeler / ManufacturerCephalon, LLC
Marketing categoryNew Drug Application (innovator) · App NDA022249
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBENDAMUSTINE HYDROCHLORIDE (25 mg/5mL)
Marketing started20100105
Package count1

External sources

Source: openFDA. Public-domain (CC0).